- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 216.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 215.47M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 180.86M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.48M |
| Capex | Q1 2026 · Mar 31, 2025 | $10.07M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$222.74M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$262.09M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $542.22M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $540.96M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $582.19M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $510.45M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $704.85M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $738.98M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $99.16M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $285.38M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $361.01M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $468.87M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.37B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.53B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.61B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.79B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.08B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.26B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.76 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.42 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.76 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.42 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $247.26M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $147.55M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $209.49M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $152.58M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$163.56M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$256.58M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$153.32M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$248.14M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $47.42M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $21.28M |
| Revenue | Q1 2026 · Mar 31, 2026 | $305.96M |
| Revenue | Q1 2026 · Mar 31, 2025 | $92.82M |